| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/20/2009 | EP2060563A1 Cyclic aminoalkylcarboxamide derivative |
| 05/20/2009 | EP2060562A1 Dioxoanthracene sulphonate derivatives |
| 05/20/2009 | EP2060300A1 C-19 steroids for therapeutic uses |
| 05/20/2009 | EP2060273A2 MRI contrast medium composition for oral administration |
| 05/20/2009 | EP2060272A2 Vitamin-mitomycin conjugates |
| 05/20/2009 | EP2060270A2 Fibroblast growth factor receptor-1 inhibitors and methods of treatment thereof |
| 05/20/2009 | EP2060264A1 Agent for treating eye diseases |
| 05/20/2009 | EP2060262A1 Composition comprising at least one nucleosidic moiety as a therapeutic agent, and ckc |
| 05/20/2009 | EP2060261A1 C-19 steroids for cosmetic and further uses |
| 05/20/2009 | EP2060260A1 Therapeutic agents useful for treating pain |
| 05/20/2009 | EP2060259A1 Medical compositions for intravesical treatment of bladder cancer |
| 05/20/2009 | EP2060258A1 Use of CRTH2 antagonist compounds in therapy |
| 05/20/2009 | EP2060257A1 Prevention and treatment of secondary infections following viral infection |
| 05/20/2009 | EP2060256A1 Pharmaceutical and nutraceutical compositions based on menaquinols |
| 05/20/2009 | EP2060255A2 Methods and compositions for prevention and treatment of inflammatory disease, autoimmune disease, and transplant rejection |
| 05/20/2009 | EP2060253A1 Pharmaceutical forms for the release of active compounds |
| 05/20/2009 | EP2060252A1 New formulation of galactosylceramide derivatives |
| 05/20/2009 | EP2060183A2 Enteric formulations of proanthocyanidin polymer antidiarrheal compositions |
| 05/20/2009 | EP2059802A2 Methods for designing parp inhibitors and uses thereof |
| 05/20/2009 | EP2059597A2 Rnai-mediated inhibition of gremlin for treatment of iop-related conditions |
| 05/20/2009 | EP2059595A2 Compositions and methods for modulating mtor signaling |
| 05/20/2009 | EP2059593A2 Treating or preventing cancers over-expressing reg4 or kiaa0101 |
| 05/20/2009 | EP2059522A2 Phosphonate and phosphinate compounds as glucokinase activators |
| 05/20/2009 | EP2059521A1 Pyrazolo[1,5-a]pyrimidines, processes, uses and compositions |
| 05/20/2009 | EP2059520A1 1,4,5,6, 7,8-hexahydro-i^1s-triaza-azulene derivatives as orexin receptor antagonists |
| 05/20/2009 | EP2059519A2 Nitrogen-containing heterocyclic compounds and methods of use thereof |
| 05/20/2009 | EP2059518A2 Salts of benzimidazolyl pyridyl ethers and formulations thereof |
| 05/20/2009 | EP2059517A1 Pyrimidine compounds for treating gpr119 related disorders |
| 05/20/2009 | EP2059516A1 Pyridine compounds for treating gpr119 related disorders |
| 05/20/2009 | EP2059514A2 Novel belactosin derivatives as therapeutic agents/biological probes and their synthesis |
| 05/20/2009 | EP2059512A1 P38 kinase inhibitors |
| 05/20/2009 | EP2059511A1 Sulphoximides as protein kinase inhibitors |
| 05/20/2009 | EP2059509A2 Process for the preparation of montelukast, and intermediates therefor |
| 05/20/2009 | EP2059508A1 5,6-bisaryl-2-pyridine-carboxamide derivatives, preparation and application thereof in therapeutics as urotensin ii receptor antagonists |
| 05/20/2009 | EP2059507A2 Ep2 agonists |
| 05/20/2009 | EP2059506A1 Novel piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 05/20/2009 | EP2059505A2 Muscarinic receptor antagonists |
| 05/20/2009 | EP2059504A1 3-substituted-1,5-diarly-2-alkyl-pyrroles highly selective and orally effective cox-2 inhibitors |
| 05/20/2009 | EP2059500A2 Inhibitors of zinc proteases thioaryl substituted and their use |
| 05/20/2009 | EP2059305A2 Inhibitors of undecaprenyl pyrophosphate synthase |
| 05/20/2009 | EP2059304A1 Treating mycobacterial infections with cyclipostins |
| 05/20/2009 | EP2059260A2 Pharmaceutical compositions comprising hgh for oral delivery |
| 05/20/2009 | EP2059259A1 Pharmaceutical compositions for the treatment of fungal infections |
| 05/20/2009 | EP2059254A1 Sensitization of tumor cells to radiation therapy through the administration of endothelin agonists |
| 05/20/2009 | EP2059250A2 Compounds for the treatment of angiogenesis |
| 05/20/2009 | EP2059249A2 Pharmaceutical compositions for the treatment of inflammatory or obstructive airway diseases |
| 05/20/2009 | EP2059248A1 Pharmaceutical preparation for the alleviation of endometriosis |
| 05/20/2009 | EP2059247A1 Method and composition for promoting gastrointestinal bicarbonate secretion |
| 05/20/2009 | EP2059246A2 Therapeutic compositions comprising a specific endothelin receptor antagonist and a pde5 inhibitor |
| 05/20/2009 | EP2059245A1 Bifeprunox doses for treating schizophrenia |
| 05/20/2009 | EP2059244A1 Titration schedule for bifeprunox for treating schizophrenia and kits for use therein |
| 05/20/2009 | EP2059243A1 Buprenophine-wafer for drug substitution therapy |
| 05/20/2009 | EP2059242A1 Methods of lowering glucose levels |
| 05/20/2009 | EP2059241A1 Pharmaceutical combinations for lipid management and in the treatment of atherosclerosis and hepatic steatosis |
| 05/20/2009 | EP2059240A1 Novel composition and method effective in inhibiting the atherogenic process |
| 05/20/2009 | EP2059239A2 Enhanced mucosal hydration and mucosal clearance by treatment with sodium channel blockers and osmolytes |
| 05/20/2009 | EP2059238A2 Therapeutic compounds for diseases and disorders |
| 05/20/2009 | EP2059237A2 Methods of enhancing mucosal hydration and mucosal clearance by treatment with sodium channel blockers and osmolytes |
| 05/20/2009 | EP2059236A2 Combination with bis(thiohydrazide amides) for treating cancer |
| 05/20/2009 | EP2059235A2 Method for prevention and treatment of alzheimers |
| 05/20/2009 | EP2059234A1 Method for reducing or alleviating inflammation in the digestive tract |
| 05/20/2009 | EP2059233A2 Inhibitors of protein phosphatase 1, gadd34 and protein phosphatase 1/gadd34 complex, preparation and uses therof |
| 05/20/2009 | EP2059232A1 Use of polyols to obtain stable polymorphous forms of rifaximin |
| 05/20/2009 | EP2059231A1 Pharmaceutical compositions comprising cefquinome |
| 05/20/2009 | EP2059224A1 Skin care composition |
| 05/20/2009 | EP2059215A1 Improved preparation for reducing and/or preventing body fat and respective uses, in particular together with a dressing material |
| 05/20/2009 | EP2059139A1 Tasteless nutritional supplement containing free amino acids |
| 05/20/2009 | EP2059137A2 Apparatus and process for manufacturing food products with omega-3 polyunsaturated fatty acids |
| 05/20/2009 | EP1915166B1 Marrubiin and composition for reducing snoring, package and method |
| 05/20/2009 | EP1888058B1 Inhibitors of soluble adenylate cyclase |
| 05/20/2009 | EP1883302A4 Jak kinase inhibitors and their uses |
| 05/20/2009 | EP1835922B1 Combination treatment for multiple sclerosis |
| 05/20/2009 | EP1807423B1 Quinolinone-carboxamide compounds |
| 05/20/2009 | EP1773348A4 Tetrapeptide analogs |
| 05/20/2009 | EP1737441A4 Beneficial effects of increasing local blood flow |
| 05/20/2009 | EP1607091B1 Antihepatitis c virus agent and anti-hiv agent |
| 05/20/2009 | EP1565467B1 Novel vitronectin receptor antagonist derivatives, method for preparing same, use thereof as medicines and pharmaceutical compositions containing same |
| 05/20/2009 | EP1562620B1 Modified cytokines for use in cancer therapy |
| 05/20/2009 | EP1562575B1 Fused cycloalkyl amides and acids and their therapeutic applications for the treatment of i.a. epilepsy |
| 05/20/2009 | EP1534686B1 Nf-kb inhibitors and uses thereof |
| 05/20/2009 | EP1513528B1 Pharmaceutical composition containing stabilised amorphous form of donepezil hydrochloride |
| 05/20/2009 | EP1423089B1 Cosmetic and/or pharmaceutical preparations containing an extract from pterocarpus marsupium |
| 05/20/2009 | EP1414451B1 Opioid agonist formulations with releasable and sequestered antagonist |
| 05/20/2009 | EP1401492B1 Ltb4 as vaccine adjuvant |
| 05/20/2009 | EP1392691B1 Antifungal 4-substituted 5,6-dihydro-4h-pyrrolo[1,2-a] [1,4] benzodiazepines |
| 05/20/2009 | EP1365760B1 Preparations and use of an ah receptor ligand, 2-(1'h-indole-3'-carbonyl)-thiazole-4-carboxylic acid methyl ester |
| 05/20/2009 | EP1354888B1 Glucopyranosyloxypyrazole derivatives and use thereof in medicines |
| 05/20/2009 | EP1352638B1 Cosmetics for alleviating skin irritation |
| 05/20/2009 | EP1330265B1 Formulations comprising dextrin polymers in combination with sugars for the delivery of nucleic acids |
| 05/20/2009 | EP1310502B1 Phosphonocephem compound |
| 05/20/2009 | EP1231910B1 Pentamidine for treating cancer |
| 05/20/2009 | EP1208113B1 17beta-acyl-alpha-propynyl-11beta-(cyclic amino)aryl steroids and their derivatives having antagonist hormonal properties |
| 05/20/2009 | EP1052974B1 Pharmaceutical formulation containing epothilone |
| 05/20/2009 | EP0988274B1 Carboxylic acids and derivatives thereof and pharmaceutical compositions containing them |
| 05/20/2009 | DE60226032T2 Neue imidazolidinderivate, deren herstellung und verwendung als vla4-antagonisten New imidazolidine derivatives, their preparation and use as VLA4 antagonists |
| 05/20/2009 | DE10248412B4 Suppositorium zur Behandlung oder Vorbeugung von Hypoglykämie Suppository for the treatment or prevention of hypoglycemia |
| 05/20/2009 | DE102008052054A1 Cosmetic and/or pharmaceutical preparation, useful e.g. for hair care, hair cleaning and hair coloring, and for decorative cosmetics e.g. lipstick and for post-sun treatment or sanitary wipes, comprises dialkyl(ene) ether compound |
| 05/20/2009 | DE102007055344A1 Neue Verwendung von Omega-3-Fettsäure(n) New use of omega-3 fatty acid (s) |
| 05/20/2009 | DE102007054985A1 Topical product, useful e.g. to prevent/treat relapses by herpes simplex I, comprises histone deacetylase activator comprising resveratrol, quercetin and/or luteolin, and additionally vitamin B12, vitamin B6, folic acid and betaine |
| 05/20/2009 | DE102007054877A1 Use of hyaluronidase e.g. as a drug for the treatment of profibrotic metabolic disorder, fibrotic liver disease, chronic viral liver disease, portal hypertension, chronic hepatitis C and hepatocellular carcinoma |